- Previous Close
404.50 - Open
400.05 - Bid --
- Ask --
- Day's Range
382.90 - 407.95 - 52 Week Range
280.40 - 562.00 - Volume
69,122 - Avg. Volume
123,226 - Market Cap (intraday)
15.461B - Beta (5Y Monthly) 0.06
- PE Ratio (TTM)
22.63 - EPS (TTM)
17.06 - Earnings Date --
- Forward Dividend & Yield 1.25 (0.25%)
- Ex-Dividend Date Sep 5, 2024
- 1y Target Est
--
Heranba Industries Limited engages in the manufacture and sale of various agrochemicals in India. It offers intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, bifenthrin, and propiconazole. The company also provides fungicides comprising tricyclazole, hexaconazole, tebuconazole, thifluzamide, picoxystrobin, and dodine; herbicides, which include bispyribac sodium, clodinafop, tembotorine, and pendimethalin; and plant growth regulators. In addition, it offers formulations consisting of emulsifiable concentrate, capsule suspension, suspension concentrate, oil dispersion, concentrated aqueous emulsions, wettable powder, suspoemulsion, water dispersible granule, zc formulation, soluble liquid, flowable concentration, and soluble powder. The company exports its products to approximately 74 countries. The company was formerly known as Heranba Industrial Chemicals Limited and changed its name to Heranba Industries Limited in July 1996. Heranba Industries Limited was incorporated in 1992 and is based in Mumbai, India.
www.heranba.co.in875
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: HERANBA.NS
View MorePerformance Overview: HERANBA.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HERANBA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HERANBA.NS
View MoreValuation Measures
Market Cap
15.46B
Enterprise Value
17.41B
Trailing P/E
22.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.20
Price/Book (mrq)
1.73
Enterprise Value/Revenue
1.36
Enterprise Value/EBITDA
12.02
Financial Highlights
Profitability and Income Statement
Profit Margin
4.48%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
12.78B
Net Income Avi to Common (ttm)
572.7M
Diluted EPS (ttm)
17.06
Balance Sheet and Cash Flow
Total Cash (mrq)
395.5M
Total Debt/Equity (mrq)
19.34%
Levered Free Cash Flow (ttm)
--